Tissue-specific consequences of the anti-adenoviral immune response: Implications for cardiac transplants

Nature Medicine

Volumn 5, Issue 10, 1999, Pages 1143-1149

  Chan, Sherri Y ^a   Li, Kewang ^a   Piccotti, Joseph R ^a   Louie, Marisa C ^a   Judge, Thomas A ^b   Turka, Laurence A ^b   Eichwald, Ernst J ^c   Bishop, D Keith ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEART GRAFT; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART TRANSPLANTATION; INFUSIONS, INTRAVENOUS; MICE; MICE, INBRED C57BL; TRANSGENES; TRANSPLANTATION, ISOGENEIC;

EID: 0032861561     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/13467     Document Type: Article

References (31)

1. Wilson, J.M. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med. 334, 1185-1187 (1996).
2. Trapnell, B.C. & Gorziglia, M. Gene therapy using adenoviral vectors. Curr. Opin. Biotech. 5, 617-625 (1994).
3. Yang, Y. et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411 (1994).
4. Yang, Y., Li, Q., Ertl, H.C.J. & Wilson, J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995).
5. Tripathy, S.K., Black, H.B., Goldwasser, E. & Leiden, J. M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550 (1996).
6. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C.J. & Wilson, J. M. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144 (1996).
7. Yang, Y. & Wilson, J. M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155, 2564-2570 (1995).
8. DeMatteo, R.P., Markmann, J.F., Kozarsky, K.F., Barker, C.F. & Raper, S.E. Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther. 3, 4-12 (1996).
9. Vilquin, J.-T. et al. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Human Gene Ther. 6, 1391-1401 (1995).
10. Gao, X. & Huang, L. Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722 (1995).
11. Crystal, R.G. The gene as the drug. Nature Med. 1, 15-17 (1995).
12. Gunzburg, W. H., & Salmons, B. Development of retroviral vectors as safe, targeted gene delivery systems. J. Mol. Med. 74, 171-182 (1996).
13. Larsen, C.P. et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381, 434-438 (1996).
14. Bishop, D.K., Shelby, J. & Eichwald, E. J. Mobilization of T lymphocytes after cardiac transplantation: Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory enothelial development, graft infiltration, and acute allograft rejection. Transplantation 53, 849-857 (1997).
15. Merrick, A.F., Shewring, L.D., Sawyer, G.J., Gustafsson, K.T. & Fabre, J.W. Comparison of adenovirus gene transfer to vascular endothelial cells in cell culture, organ culture, and in vivo. Transplantation 62, 1085-1089 (1996).
16. Wang, J., Ma, Y. & Knechtle, S.J. Adenovirus-mediated gene transfer into rat cardiac allografts: Comparison of direct injection and perfusion. Transplantation 61, 1726-1729 (1996).
17. Shiraishi, M. et al. Adenovirus-mediated gene transfer using ex vivo perfusion of the heart graft. Surg. Today 26, 624-628 (1996).
18. Lee, J. et al. Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J. Thorac. Cardiovasc. Surg. 111, 246-252 (1996).
19. Drazan, K.E. et al. Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J. Surg. Res. 59, 299-304 (1995).
20. Drazan, K.E. et al. Adenovirus-mediated gene transfer in the transplant setting: Early events after orthotopic transplantation of liver allografts expressing TGF-β1. Transplantation 62, 1080-1084 (1996).
21. Shaked, A. et al. Adenovirus-mediated gene transfer in the transplant setting: II. Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation 57, 1508-1511 (1994).
22. DeMatteo, R.P. et al. Immunologic barriers to hepatic adenoviral gene therapy for transplantation: Cellular and humoral responses limit transgene expression in mouse liver. Transplantation 63, 315-319 (1997).
23. McCoy, R.D., Davidson, B.L., Roessler, B.J., Huffnagle, B.B. & Simon, R.H. Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: Effects on vector-induced inflammation. Gene Ther. 2, 437-442 (1995).
24. Qin, L. et al. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. Hum. Gene Ther. 8, 1365-1374 (1997).
25. Olthoff, K.M. et al. Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig, Nature Med. 4, 194-200 (1998).
26. Austyn, J.M. et al. Isolation and characterization of dendritic cells from mouse heart and kidney. J. Immunol. 152, 2401-2410 (1994).
27. Larsen, C.P., Morris, P. J. & Austyn, J.M. Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection. J. Exp. Med. 171, 307-314 (1990).
28. Garside, P. et al. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281, 96-99 (1998).
29. Logan, J. & Shenk, T. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc. Natl. Acad. Sci USA 81, 3655-3659 (1984).
30. Ye, X. et al. Prolonged metabolic correction in adult ornithine transcarbamylase-deficient mice with adenoviral vectors. J. Biol. Chem. 271, 3639-3646 (1996).
31. Corry, R.J., Winn, H.J. & Russell, P.S. Primarily vascularized allografts of hearts in mice: The role of H-2D, H-2K, and Non-H-2 antigens in rejection. Transplantation 16, 343-350 (1973).